Measurement of apixaban concentrations in different human biological fluids by UHPLC-MS/MS. Clinical pharmacokinetic application in a subject with chronic kidney disease and nonvalvular atrial fibrillation on haemodialysis.

Raúl Rigo-Bonnin,Elena Rosselló-Palmer, Arnau Sánchez-García, Mireia Pallarés-Borràs, Yurema Martínez,Sebastián Videla,Aurema Otero,Núria Lloberas,Miguel Hueso

Clinica chimica acta; international journal of clinical chemistry(2023)

引用 0|浏览4
暂无评分
摘要
The validated UHPLC-MS/MS procedures could help support a pharmacokinetic study in non-valvular atrial fibrillation subjects with chronic kidney disease undergoing haemodialysis and apixaban-based anticoagulant therapy.
更多
查看译文
关键词
Apixaban,Plasma,Dialysate liquid,UHPLC-MS/MS,Urine
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要